Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urogenital Neoplasms 2Lung Neoplasms 2Colitis 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Solid Carcinoma 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Neoplasms 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Diarrhea 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Cachexia 1Breast Neoplasms 1

Interventions

paricalcitol 1mitazalimab 1Specimen Handling 1Positron Emission Tomography Computed Tomography 1Parturition 1Oxaliplatin 1Neoadjuvant Therapy 1Losartan 1Leucovorin 1Irinotecan 1Hydroxychloroquine 1Glucose 1Gemcitabine 1Fluorouracil 1Fecal Microbiota Transplantation 1Contrast Media 1Capecitabine 1Biopsy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Ductal Adenocarcinoma × Fecal Microbiota Transplantation × 90 days × Clear all
NCT04975217 2026-05-22

Fecal Microbial Transplants for the Treatment of Pancreatic Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Suspended
10 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡